<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00311298</url>
  </required_header>
  <id_info>
    <org_study_id>NIMR-UC-2006-01</org_study_id>
    <nct_id>NCT00311298</nct_id>
  </id_info>
  <brief_title>Nutrition, Diabetes and Pulmonary TB/HIV</brief_title>
  <official_title>The Role of Nutritional Support and Diabetes During Treatment of Pulmonary TB: Two Randomized Nutritional Supplementation Trials in Tanzania</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute for Medical Research, Tanzania</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Danish Medical Research Council</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Danish Council for Development Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Copenhagen</source>
  <brief_summary>
    <textblock>
      We propose a randomised trial among pulmonary TB patients, examined and treated as part of
      the national TB control programme (WHO, 2003). The aim is to improve TB treatment outcome in
      high TB and HIV burden countries. The overall objective of the proposed trial is to assess
      the effect of nutritional support on TB treatment outcomes, and to assess the role of
      diabetes on risk and severity of TB, and TB treatment outcomes. The study will be conducted
      in Mwanza Tanzania. All patients will initially be examined for HIV and diabetes. A total of
      500 found pulmonary TB smear-positive (PTB+) and HIV positive (HIV+) will be randomised to a
      daily supplement of 1 versus 6 energy-protein bars throughout treatment, both with full
      multi-micronutrient (MN) content. A total of 1500 found pulmonary TB smear-negative (PTB-,
      irrespective of HIV status) and PTB+ and HIV negative (HIV-) will be randomised to 1 daily
      energy-protein bar containing either low or high MN content.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2006</start_date>
  <completion_date type="Actual">March 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Weight gain</measure>
    <time_frame>2 and 5 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Grip strength</measure>
    <time_frame>2 and 5 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arm muscle and arm fat areas</measure>
    <time_frame>2 and 5 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity</measure>
    <time_frame>2 and 5 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HIV load</measure>
    <time_frame>2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CD4 count</measure>
    <time_frame>2 and 5 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum acute phase reactants</measure>
    <time_frame>2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>12 month</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">1250</enrollment>
  <condition>Tuberculosis</condition>
  <condition>HIV</condition>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>No micronutrients</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Biscuit without additional micronutrients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Micronutrients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Biscuit with additional micronutrients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1 biscuit</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 biscuit with micronutrients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>6 biscuits</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 biscuit with micronutrients, plus 5 biscuits without additional micronutrients</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Multimicronutrients</intervention_name>
    <description>Randomised, double-blind trial among pulmonary TB patients, except those who are found to be sputum positive and HIV positive. Both arms received a daily biscuit weighing 30 g (4.5 g protein, 615 kJ). The biscuit given to the No micronutrient-arm contained no additional micronutrients. The biscuit given to the Micronutrient-arm contained the following micronutrients: vitamin A 5000 IU, vitamin B1 20 mg, vitamin B2 20 mg, vitamin B6 25 mg, vitamin B12 50 microg, folic acid 0.8 mg, niacin 40 mg, vitamin C 200 mg, vitamin E 60 mg, vitamin D3 5 µg / 200 IU, selenium 0.2 mg, copper 5 mg, and zinc 30 mg. The intervention was given for 60 days during initial TB treatment.</description>
    <arm_group_label>No micronutrients</arm_group_label>
    <arm_group_label>Micronutrients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Energy and proteins</intervention_name>
    <description>Randomised, single-blind trial among sputum-positive HIV-coinfected pulmonary TB patients. Both arms received a daily for biscuit weighing 30 g (4.5 g protein, 615 kJ), with micronutrients (vitamin A 5000 IU, vitamin B1 20 mg, vitamin B2 20 mg, vitamin B6 25 mg, vitamin B12 50 microg, folic acid 0.8 mg, niacin 40 mg, vitamin C 200 mg, vitamin E 60 mg, vitamin D3 5 µg / 200 IU, selenium 0.2 mg, copper 5 mg, and zinc 30 mg). The experimental arm received an additional 5 biscuits without additional micronutrients. Thus, both arms received the same amount of micronutrients. However, the intervention arm received 3690 kJ and 27 g protein per day, while the control arm received 615 kJ and 4.5 g protein. The intervention was given for 60 days during initial TB treatment.</description>
    <arm_group_label>1 biscuit</arm_group_label>
    <arm_group_label>6 biscuits</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  New sputum smear positive or negative pulmonary TB patients

        Exclusion Criteria:

          -  pregnant, terminally ill, other serious diseases (except HIV and diabetes),
             non-residents
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nyagosya Range, MSc, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Muhimbili Medical Centre, NIMR</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Henrik Friis, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Copenhagen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mwanza Medical Centre, NIMR</name>
      <address>
        <city>Mwanza</city>
        <country>Tanzania</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Tanzania</country>
  </location_countries>
  <link>
    <url>http://www.nimr.or.tz/</url>
    <description>National Institute of Medical Research</description>
  </link>
  <reference>
    <citation>Range N, Changalucha J, Krarup H, Magnussen P, Andersen AB, Friis H. The effect of multi-vitamin/mineral supplementation on mortality during treatment of pulmonary tuberculosis: a randomised two-by-two factorial trial in Mwanza, Tanzania. Br J Nutr. 2006 Apr;95(4):762-70.</citation>
    <PMID>16571156</PMID>
  </reference>
  <verification_date>August 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 3, 2006</study_first_submitted>
  <study_first_submitted_qc>April 3, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 5, 2006</study_first_posted>
  <last_update_submitted>August 3, 2009</last_update_submitted>
  <last_update_submitted_qc>August 3, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 4, 2009</last_update_posted>
  <responsible_party>
    <name_title>Prof. Henrik Friis</name_title>
    <organization>University of Copenhagen</organization>
  </responsible_party>
  <keyword>tuberculosis</keyword>
  <keyword>hiv</keyword>
  <keyword>diabetes</keyword>
  <keyword>protein-energy</keyword>
  <keyword>micronutrients</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Tuberculosis</mesh_term>
    <mesh_term>Tuberculosis, Pulmonary</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Micronutrients</mesh_term>
    <mesh_term>Trace Elements</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

